2026. ADJUVANT XELOX CHEMOTHERAPY OUTCOMES IN HIGH-RISK STAGE II AND STAGE III COLON CANCER: EVIDENCE FROM THAI BINH GENERAL HOSPITAL. Vietnam Journal of Community Medicine. 67, 10 (Oct. 2026). DOI:https://doi.org/10.52163/yhc.v67i10.6908.